«We present an interdisciplinary approach to studying immunotherapy and
immune surveillance of tumors,» said Benjamin Greenbaum, PhD, the senior author, who is affiliated
with the departments of Medicine, Hematology and Medical Oncology, Pathology, and Oncological Sciences at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.